*All sessions are listed in Central European Time
Friday, September 30
|
|
14:00
|
Opening Remarks
Symposium Chairmen
Ian A. Greer, UK; Benjamin Brenner, Israel; Manuel Monreal, Spain
|
|
14:10 - 15:20
|
Session 1: Cancer And Thrombosis In Women
|
|
Chairs:
|
Andres Muñoz; Lucy Norris
|
|
14:10
|
Thrombo-inflammation in cancer
Joseph S. Palumbo, USA
|
|
14:25
|
Outcome of CAT: solid tumors versus hematological malignancies
Jean M. Connors, USA
|
|
14:40
|
Update of guidelines for CAT management
Corinne Frere, France
|
|
14:55
|
Selected Oral Communications
|
|
"Myeloid-derived suppressor cells potentially contribute to progression of pregnancy-associated non-Hodgkin lymphoma" Netanel A. Horowitz, et al.; Israel
|
|
15:00
|
Q&A and Panel Discussion
|
|
15:20 - 16:00
|
Poster Session
|
|
Chair:
|
Dorit Blickstein
|
|
P-01
|
“Pharmacokinetics of curative tranexamic acid in parturient women undergoing cesarean delivery” Anne-Sophie Ducloy-Bouthors, et al.; France
|
|
P-02
|
“Vital netosis vs. suicidal netosis during normal pregnancy and preeclampsia” Florence Guillotin, et al.; France, Russia
|
|
P-03
|
“Thrombophilia testing in women with thrombosis during and post Covid-19 infection” Evgenia Moustaferi, et al.; Greece
|
|
P-04
|
“Risk factors for venous thromboembolism in pregnant women with COVID-19” Monica Gonzalez Alcantara, et al.; Argentina
|
|
P-05
|
“Determination of anti-Xa levels in pregnancy: Experience of our center” María B Moreno Risco, et al.; Badajoz
|
|
P-06
|
“Management of severe factor VII deficiency in the reproductive age” Ron Hoffman, et al.; Israel
|
|
16:00-16:20
|
Break
|
|
16:20 - 17:35
|
Session 2: Pregnancy Complications
|
|
Chairs:
|
Jean-Christophe Gris; Benjamin Brenner |
|
16:20
|
Fetal hemostasis
Marilyn J. Manco-Johnson, USA
|
|
16:35
|
Risk-assessment models for pregnancy complications
Céline Chauleur, France
|
|
16:50
|
The impact of advanced maternal age on pregnancy outcome
Amy Wooldridge, Canada
|
|
17:05
|
Selected Oral Communications
|
|
"Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without thrombophilia" Luca Spiezia, et al.; Italy
|
|
"Association between ABO blood group and recurrent spontaneous abortion in the Middle East countries: A systematic review and meta-analysis" Luca Spiezia, at el; Italy
|
|
17:15
|
Q&A and Panel Discussion
|
Saturday, October 1
|
|
14:00-15:15
|
Session 3: Challenging Clotting Issues in COVID-19
|
|
Chairs:
|
Emmanuel Papadakis; Ismail Elalamy
|
|
14:00
|
Complement-mediated coagulopathy
Barry Jacobson, South Africa
|
|
14:15
|
Lab testing for vaccine-induced thrombotic thrombocytopenia
Emmanuel J. Favaloro, Australia
|
|
14:30
|
Anti-coagulation strategies in COVID-19 management
Alex C. Spyropoulos, USA
|
|
14:45
|
Selected Oral Communications
|
|
"Venous thromboembolism (VTE) in hospitalized pregnant patients with COVID-19: Results from a prophylactic anticoagulation protocol" Venina V Barros, et al.; Brazil
|
|
"Monitoring the spread and evolution of SARs-CoV2 infection at a Greek General Hospital from April 2021 to June 2022, focusing on the results on the female population" Sofia Likousi, et al; Greece
|
|
14:55
|
Q&A and Panel Discussion
|
|
15:15-15:35
|
Break
|
|
15:35-17:00
|
Sanofi Educational Webinar
VTE & Women: From risk reduction to an optimized patient management
|
|
Chairs:
|
Prof. A.J. Kakkar & Prof. C. Nelson-Piercy
|
| > |
VTE management in obstetrics: optimal dose and duration
Saskia Middeldorp, The Netherlands
|
| > |
Deaths from VTE in pregnancy in the UK: is prevention worth it?
Catherine Nelson-Piercy, UK |
| > |
COVID-19 and pregnancy
Stephen Lapinsky, Canada |
|
17:00-17:10
|
Break
|
|
17:10-18:30
|
Session 4: Bleeding Disorders
|
|
Chairs:
|
Rezan Abdul Kadir; Maha Othman
|
|
17:10
|
An update on the pathophysiology of immune thrombocytopenia
John W. Semple, Sweden
|
|
17:25
|
Uncommon hereditary bleeding disorders in women
Ophira Salomon, Israel
|
|
17:40
|
Challenges in the management of women with type 2B VWD during pregnancy and postpartum
Predrag Miljic, Serbia
|
|
17:55
|
Selected Oral Communications
|
|
"The antifibrinolytic dose-response relationship for tranexamic acid in postpartum haemorrhage during caesarean delivery: the TRACES double-blind, placebo-controlled, multicentre, dose-ranging, biomarkers study. Multicenter double–blind placebo-controlled dose-ranging (TRACES) ancillary study" Anne-Sophie Ducloy-Bouthors, et al.; France
|
|
"Saved by the blood bank: Massive feto-maternal hemorrhage detected during maternal blood typing" Lilach Bonstein, et al.; Israel
|
|
"The role of TEG6S in managing major obstetric haemorrhage" Mia Ballantyne, et al: UK
|
|
18:10
|
Q&A and Panel Discussion
|
Sunday, October 2
|
|
14:00-15:25
|
Session 5: Venous Thromboembolism in Women
|
|
Chairs:
|
Cecilia Becattini; Menno V. Huisman
|
|
14:00
|
Hormonal therapy and thrombosis
Saskia Middeldorp, the Netherlands
|
|
14:15
|
Risk stratification of pulmonary embolism
David Jimenez, Spain
|
|
14:30
|
Post-thrombotic syndrome in women
Susan R. Kahn, Canada
|
|
14:45
|
Abnormal uterine bleeding in women receiving anticoagulation for VTE
Gabrielle Sarlon-Bartoli, France
|
|
15:00
|
Selected Oral Communications
|
|
"Combined oral contraceptive-associated venous thromboembolism revealing an antiphospholopid syndrome: International retrospective study of outcomes" Jean-Christophe Gris, et al.; France, Russia
|
|
15:05
|
Q&A and Panel Discussion |
|
15:25-15:40
|
Break
|
|
15:40-16:55
|
Session 6: Systemic Syndromes
|
|
Chairs:
|
Roopen Arya; Zoubida Tazi Mezalek
|
|
15:40
|
Hemostasis in extremes of body weight
Beverley Hunt, UK
|
|
15:55
|
Obstetric APS
Jean-Christophe Gris, France
|
|
16:10
|
COVID-19 and Coagulopathies in Pregnancy
Maha Othman, Canada
|
|
16:25
|
Selected Oral Communications
|
|
"Antiphospholipid syndrome (APS) in pregnancy: Maternal and perinatal outcome after first line treatment with enoxaparin and low dose aspirin (LDA)" Beatriz Eugenia Grand, et al.; Argentina
|
|
"Hereditary spherocytosis in pregnancy; a systematic review of prognostic factors, maternal and fetal outcomes" Zara Arain, Rezan Abdul Kadir; UK
|
|
16:30
|
Q&A and Panel Discussion
|
|
16:55-17:15
|
Break |
|
17:15-18:20
|
Session 7: Genomics and Data Integration: Implications for Women’s Health
|
|
Chairs
|
Ian A. Greer; Manuel Monreal
|
|
17:15
|
International Network of Venous Thromboembolism (INVENT)
Marc Rodger, Canada
|
|
17:30
|
Sex differences in elderly patients with acute pulmonary embolism differences
Behnood Bikdeli, USA
|
|
17:45
|
Thromboembolic risk in women with atrial fibrillation
Antonella Tufano, Italy
|
|
18:00
|
Q&A and Panel Discussion |
|
18:20
|
Concluding Remarks - Symposium Chairmen
|